hydroquinone and cyclic gmp

hydroquinone has been researched along with cyclic gmp in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oyekan, AO1
Gibson, A; Lilley, E1
Chen, CF; Huang, YT; Lin, LC; Pang, PK; Shan, J; Wang, GJ; Wu, XC1
AnggÄrd, EE; Carrier, MJ; Desai, KM; Laight, DW1
Bose, R; Cheng, ZQ; Jacobs, H; Kasian, K; Light, RB; Mink, SN; Santos Martinez, LE1

Other Studies

5 other study(ies) available for hydroquinone and cyclic gmp

ArticleYear
Role of the endothelium and cyclic GMP in renal vasodilator responses to cryptolepine in rats.
    Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:4

    Topics: Alkaloids; Animals; Antihypertensive Agents; Arginine; Cyclic GMP; Endothelium, Vascular; Hydroquinones; In Vitro Techniques; Indole Alkaloids; Indoles; Kidney; Male; Methylene Blue; Nitric Oxide; Nitroarginine; Potassium Chloride; Quinolines; Rats; Vasodilator Agents

1994
Inhibition of relaxations to nitrergic stimulation of the mouse anococcygeus by duroquinone.
    British journal of pharmacology, 1995, Volume: 116, Issue:8

    Topics: Animals; Benzoquinones; Chelating Agents; Cyclic GMP; Ditiocarb; Hydroquinones; In Vitro Techniques; Male; Mice; Muscle Relaxation; Muscle, Smooth; Nitric Oxide; Oxidation-Reduction; Superoxide Dismutase; Superoxides

1995
Vasorelaxing action of rutaecarpine: effects of rutaecarpine on calcium channel activities in vascular endothelial and smooth muscle cells.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:3

    Topics: 4-Aminopyridine; Alkaloids; Animals; Aorta, Thoracic; Calcium; Calcium Channels; Calcium Channels, L-Type; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Hydroquinones; In Vitro Techniques; Indole Alkaloids; Isometric Contraction; Male; Membrane Potentials; Models, Cardiovascular; Muscle, Smooth, Vascular; Nitroarginine; Norepinephrine; Patch-Clamp Techniques; Potassium Channel Blockers; Quinazolines; Rats; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents

1999
Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant, obese Zucker rat in vivo.
    European journal of pharmacology, 2000, Aug-18, Volume: 402, Issue:1-2

    Topics: Acetylcholine; Animals; Antioxidants; Area Under Curve; Body Weight; Buthionine Sulfoximine; Cyclic GMP; Diabetes Mellitus, Type 2; Endothelium, Vascular; Enzyme Inhibitors; Hemodynamics; Hydroquinones; Insulin Resistance; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Obesity; Oxidants; Rats; Rats, Zucker

2000
Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:4

    Topics: Aminoquinolines; Animals; Carotid Artery, Internal; Catalase; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclooxygenase Inhibitors; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Free Radical Scavengers; Guanylate Cyclase; Humans; Hydrogen Peroxide; Hydroquinones; In Vitro Techniques; Indomethacin; Mannitol; Mesenteric Artery, Superior; Methylene Blue; Muramidase; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxadiazoles; Phenylephrine; Prostaglandins; Protein Kinase Inhibitors; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Sepsis; Signal Transduction; Soluble Guanylyl Cyclase; Thionucleotides; Time Factors; Vasoconstrictor Agents; Vasodilation

2008